Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Addition of UT-15C SR to Pulmonary Arterial Hypertension Patients Currently Receiving Tyvaso®

The recruitment status of this study is unknown because the information has not been verified recently.
Verified February 2013 by United Therapeutics.
Recruitment status was  Active, not recruiting
Information provided by (Responsible Party):
United Therapeutics Identifier:
First received: November 14, 2011
Last updated: February 5, 2013
Last verified: February 2013
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: March 2013
  Estimated Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)